ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples